Nonreactive Analytical, Testing, Or Indicating Compositions Patents (Class 252/408.1)
  • Patent number: 7202087
    Abstract: A solid heparin tablet composition has a melting point of 25° C. or higher and is a continuous lipid component containing one or more polar lipids, one or more non-polar lipids, optionally one or several of water and mono- to trivalent alcohol in an amount of up to 15% by weight of the composition, and native heparin or fractionated heparin. Also described is a corresponding tablet, processes for production of the composition and the tablet, and a method of preventing or treating conditions amenable to preventive or therapeutic treatment by administration of the tablet.
    Type: Grant
    Filed: June 12, 2003
    Date of Patent: April 10, 2007
    Assignee: LTP Lipid Technologies Provider AB
    Inventors: Bengt Herslöf, Per Tingvall
  • Patent number: 7192776
    Abstract: A synthetic urine solution and method of its manufacture are disclosed. The solution includes water having a pH between 3 and 10. The solution further includes creatinine and means for removing bacteria from the solution so as to control or eliminate sepsis of the urine solution, preferably through the use of biocide. The solution exhibits a specific gravity of from 1.005 g/cm3 to 1.025 g/cm3. Additional compounds may also be included to further enhance the aesthetics or apparent authenticity of the synthetic urine produced according to this invention.
    Type: Grant
    Filed: January 28, 2004
    Date of Patent: March 20, 2007
    Inventor: James Matthew Stephens
  • Patent number: 7169615
    Abstract: Disclosed is a method of authenticating that a test polymer is an authenticatable polymer, wherein the authenticatable polymer has an authentication signal and comprises a substrate polymer and an optically variable tag, the optically variable tag having a fluorescence emission whose wavelength and/or intensity change over time, the method comprising subjecting the test polymer to a stimulus sufficient to cause fluorescence of the optically variable tag, determining a test signal from the fluorescence of the test polymer, and authenticating that the test polymer is an authenticatable polymer if the test signal is the same as the authentication signal of the authenticatable polymer.
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: January 30, 2007
    Assignee: General Electric Company
    Inventors: Vandita Pai-Paranjape, Radislav Potyrailo, Philippe Schottland
  • Patent number: 7153403
    Abstract: A protein marker pellet for use in a gel electrophoresis system includes one or more protein markers including a protein of known molecular weight with ionic components to provide electrical conductance, and a non-protein, gel-forming material having a porosity sufficient to allow the one or more protein markers to migrate out of the protein marker pellet under the influence of an electrical field at the same rate as the ionic components.
    Type: Grant
    Filed: April 15, 2003
    Date of Patent: December 26, 2006
    Assignee: PageGel, Inc.
    Inventors: William F. Alpenfels, Patricia Marilu Vilalta
  • Patent number: 7148067
    Abstract: A thromboplastin reagent includes tissue factor, Factor VIIa, and a net negatively charged phospholipid. The thromboplastin reagent is a synthetic thromboplastin reagent, and is in dried form.
    Type: Grant
    Filed: August 31, 2004
    Date of Patent: December 12, 2006
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: James H. Morrissey, Stephanie A. Smith
  • Patent number: 7144738
    Abstract: Methods for detecting biopolymers such as proteins, peptides, and nucleic acids in a matrix are provided, in which the methods include contacting the matrix with a sensitizing reagent that includes a substituted heteroaromatic compound; contacting the matrix with a reduceable metal salt to stain the biopolymer(s); and detecting the stained biopolymer(s). Compositions for performing the methods can include sensitizing agents, staining reagents, reducing agents, enhancing agents, and destaining agents. The compositions presented are compatible with mass spectrometry, and methods are provided for staining a biopolymer using the compositions of the invention and performing mass spectrometry on one or more biopolymers identified by the staining methods.
    Type: Grant
    Filed: March 31, 2005
    Date of Patent: December 5, 2006
    Inventor: Scott Whitney
  • Patent number: 7141350
    Abstract: An article of manufacture has an environmental sensitive label with at least one cumulative time-temperature indicator and at least one thermal event indicator thereon. The cumulative time-temperature indicator and the thermal event indicator each provides an independent verification of product performance in a predetermined environment.
    Type: Grant
    Filed: September 22, 2003
    Date of Patent: November 28, 2006
    Assignee: Eastman Kodak Company
    Inventor: Jeffrey L. Hall
  • Patent number: 7141214
    Abstract: Water-based chemical indicator inks for ethylene oxide sterilization processes and methods for its use. The chemical indicator ink contains at least one pH indicator dye selected from the group consisting of Bromocresol green, Bromophenol blue, Methyl red, Ethyl orange, and combinations thereof. The pH indicator dye undergoes an irreversible color change when exposed to ethylene oxide vapor in the presence of low-temperature steam, but when exposed to other sterilization processes either does not undergo a color change or undergoes a color change that is different than is obtained when exposed to ethylene oxide.
    Type: Grant
    Filed: June 29, 2004
    Date of Patent: November 28, 2006
    Assignee: Illinois Tool Works Inc.
    Inventor: Shobha Shakher Puntambekar
  • Patent number: 7094364
    Abstract: In one embodiment, a method for authenticating that a test polymer is an authenticatable polymer is disclosed wherein the authenticatable polymer comprises a substrate polymer and a thermochromic compound, the thermochromic compound having a first signal at a first temperature and at an authenticating wavelength, and a second signal at an authenticating temperature and the authenticating wavelength, the first and second signals being different, and the authenticating temperature being greater than the first temperature, the method comprising subjecting the test polymer to a stimulus sufficient to raise a portion of the test polymer to the authenticating temperature to create a heated portion, determining a test signal of the heated portion of the test polymer at the authenticating wavelength, and authenticating that the test polymer is an authenticatable polymer if the test signal is the same as an authenticating signal of the authenticatable polymer.
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: August 22, 2006
    Assignee: General Electric Company
    Inventors: Radislav Potyrailo, Philippe Schottland
  • Patent number: 7060203
    Abstract: An electrolyte solution for a particle measuring apparatus which comprises an inorganic salt, such as sodium chloride or calcium chloride, dissolved in an organic solvent. A substance that promotes dissolution of inorganic salts is added to provide the organic solvent with sufficient electric conductivity for electrical particle measurement. Such substances include either or both: Compound (a): a zwitterionic compound or compounds, and Compound (b): a compound or compounds including a hydroxyl group and a carboxyl or an amino group in the same molecule.
    Type: Grant
    Filed: October 30, 2001
    Date of Patent: June 13, 2006
    Assignee: Sysmex Corporation
    Inventor: Kouhei Shiba
  • Patent number: 7059768
    Abstract: The invention provides a set of standards for accurately calibrating a vacuum thermogravimetric analyzer (VTGA). The invention solves the problem of calibrating a VTGA by using the actual magnetic transitions and associated transition temperatures, or Curie temperatures, TC's, of a set of standards which can be used in-situ at the location of the sample holder obviating the difficulties associated with indirect methods of calibration. The set of standards permits accurate calibration through sufficiently numerous calibration points over a rather limited low-temperature range for determining vapor pressures of compounds. The set of temperature calibration standards is fabricated from slugs of ferromagnetic material. The composition of the ferromagnetic material in each slug is altered by alloying a ferromagnetic constituent with a non-ferromagnetic constituent to provide a plurality of standards with different Curie temperature over the limited temperature range.
    Type: Grant
    Filed: March 21, 2005
    Date of Patent: June 13, 2006
    Assignee: Hitachi Global Storage Technologies Netherlands
    Inventors: Malika Dothresa Carter, Michael Andrew Parker
  • Patent number: 7026110
    Abstract: The invention concerns a reagent for determination of leucocytes and measurement of haemoglobin in a sample of blood. This reagent comprises a buffer system that is suited to adjust selectively the pH of the reagent to an acidic value, at least one detergent of cationic type, a nitrogenous compound and, optionally, at least one inorganic salt. This reagent can be used in haematological analyses in human medicine and also permits the identification of a leucocytic subpopulation, in particular the basophil polymorphonuclear leucocytes.
    Type: Grant
    Filed: March 16, 2000
    Date of Patent: April 11, 2006
    Assignee: Horiba ABX
    Inventors: Sylvie Veriac, Henri Champseix
  • Patent number: 6939715
    Abstract: A method for separating and purifying the active hematinic species present in iron-saccharidic complexes including sodium ferric gluconate complex in sucrose, ferric hydroxide-sucrose complex and ferric saccharate complex and others of similar form and function, based on separation of the iron-saccharidic complex from one or more excipients and, preferably, lyophilization. Separation of the iron-saccharidic complex permits its analytical quantification; further concentration or purification as a new and useful product; preparation of redesigned formulations for new and useful pharmaceuticals; and/or lyophilization.
    Type: Grant
    Filed: June 1, 2004
    Date of Patent: September 6, 2005
    Assignee: Chromaceutical Advanced Technologies, Inc.
    Inventors: Robert A. Beck, Robert A. Mateer, Jr.
  • Patent number: 6933152
    Abstract: An artificial mixture which simulates human feces and its method of use for fecal occult blood testing as a control material or for proficiency testing are disclosed.
    Type: Grant
    Filed: March 31, 2004
    Date of Patent: August 23, 2005
    Assignee: NERL Diagnostics
    Inventor: Marshall E. Deutsch
  • Patent number: 6929954
    Abstract: A method for separating and purifying the active hematinic species (AHS) present in iron-saccharidic compositions, including AHS such as sodium ferric gluconate complex, ferric hydroxide-sucrose complex and ferric saccharate complex and others of similar form and function. The method separates the AHS from one or more excipients and, preferably, lyophilizes the separated AHS. Separation of the AHS permits its analytical quantification, further concentration, purification and/or lyophilization as well as preparation of new and useful products and pharmaceutical compositions.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: August 16, 2005
    Assignee: Chromaceutical Advanced Technologies, Inc.
    Inventors: Robert A. Beck, Robert A. Mateer
  • Patent number: 6913932
    Abstract: A stabilization reagent composition, particularly desirable for stabilizing blood samples containing platelets, contains reactants that generate multiple species of formaldehyde-ammonium complexes; at least one inhibitor of phosphatase enzymatic activity; and at least one inhibitor of protease enzymatic activity. Blood samples and other tissues are stabilized by this composition. Such stabilized samples are produced by methods for stabilizing the tissue by contacting the sample with the composition.
    Type: Grant
    Filed: August 23, 2002
    Date of Patent: July 5, 2005
    Assignee: Beckman Coulter, Inc.
    Inventors: John A. Maples, Lori A. Charie, Daniel James Flagler, Rhonda Ann Mills, Richard Timmons
  • Patent number: 6913928
    Abstract: Disclosed are hazardous chemical simulant compositions that can be used to simulate hazardous chemicals and methods for using hazardous chemical simulants. The compositions can include a phosphor, which emits visible light in the presence of ultraviolet light. The methods of using hazardous chemical simulants includes exposing a hazardous chemical simulant to special lighting conditions so that its location can be easily detected.
    Type: Grant
    Filed: April 8, 2002
    Date of Patent: July 5, 2005
    Assignee: Technical Solutions Group International
    Inventors: Nicholas L. Teta, David Brown, Michael Glass
  • Patent number: 6899677
    Abstract: A coupling medium of a thin layer of a homogenized mixture of at least one polysaccharide or disaccharide such as trehalose; a surface-active substance such as sodium dioctylsulfosuccinate; and water acts as a coupling medium for transverse ultrasonic waves, when the homogenized mixture is applied to surfaces of a transmitting, respectively receiving, transducer for transverse ultrasonic waves; and a surface of a probe.
    Type: Grant
    Filed: August 22, 2000
    Date of Patent: May 31, 2005
    Assignee: Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
    Inventors: Frank Volke, Jürgen Meiche
  • Patent number: 6900058
    Abstract: An aqueous control solution is disclosed for use with a spectrophotometer or photometric test strip that includes a predetermined amount of an analyte, a hydrophobic reference dye and a surfactant. In one embodiment, the aqueous control solution is applied to a photometric test strip having a chemical that oxidizes glucose and consequently forms hydrogen peroxide which reacts with an indicator dye that is also present on the strip. In this embodiment, the control solution includes a predetermined amount of glucose, an infrared reference dye, sodium dodecyl sulfate, and the indicator dye, such as sulforhodamine B.
    Type: Grant
    Filed: March 11, 2003
    Date of Patent: May 31, 2005
    Assignee: Bionostics, Inc.
    Inventors: Minna A. Rannikko, Donna M. Murray, Donna M. Rafferty
  • Patent number: 6878551
    Abstract: The present invention relates to a method for detecting biopolymers in a matrix, which includes contacting the matrix with a sensitizing reagent including on one or more optionally substituted heteroaromatic compounds; contacting the matrix with one or more reduceable metal salts to stain the biopolymer; and detecting the stained biopolymer. The invention also relates to compositions for carrying out the invention and compositions made according to the invention. The invention also relates to kits for carrying out the methods of the invention.
    Type: Grant
    Filed: August 27, 2003
    Date of Patent: April 12, 2005
    Assignee: Invitrogen Corporation
    Inventor: Scott Whitney
  • Patent number: 6875373
    Abstract: A composition for use in testing smoke detectors, comprises a polyhydroxy alcohol and a surface-active agent.
    Type: Grant
    Filed: March 14, 2002
    Date of Patent: April 5, 2005
    Assignee: No-Climb Products Ltd.
    Inventor: Chinwe Elendu
  • Patent number: 6871998
    Abstract: The invention provides a method for accurately calibrating a vacuum thermogravimetric analyzer (VTGA). The invention solves the problem of calibrating a VTGA by using the actual magnetic transitions and associated transition temperatures, or Curie temperatures, Tc's, of a set of standards which can be used in-situ at the location of the sample holder obviating the difficulties associated with indirect methods of calibration. The invention encompasses a method of using a set of calibration standards comprised of a plurality of ferromagnetic slugs to provide a temperature calibration for a VTGA. The method permits accurate calibration through sufficiently numerous calibration points over a rather limited low-temperature range for determining vapor pressures of compounds. Through the use of these standards, highly accurate measurements can be made of the vapor pressures of critical hard disk drive compounds, such as lubricants, and corrosion inhibitors, that are crucial to competitive disk drive technology.
    Type: Grant
    Filed: August 1, 2003
    Date of Patent: March 29, 2005
    Assignee: Hitachi Global Storage Technologies Netherlands B.V.
    Inventors: Malika Dothresa Carter, Michael Andrew Parker
  • Patent number: 6869798
    Abstract: A lytic reagent composition and the method of use for differential analysis of leukocytes using flow cytometry are disclosed. The lytic reagent composition includes a short chain alkyl oxyethanol, such as 2-methoxyethanol, 2-ethoxyethanol, 2-propoxyethanol, or 2-isopropoxyethanol, in a sufficient amount to preserve leukocytes; a non-lysing nonionic surfactant as a debris solublizer; and an inorganic buffer to maintain pH of the lytic reagent composition in a range from 9.1 to 10.7. The lytic reagent composition is used to lyse red blood cells and preserve leukocytes, as well as used as the sheath reagent for the focus flow measurement. The lytic reagent composition, when used on a flow cytometric analyzer with multiple angle light scatter and light absorbance measurements, enables differentiation of leukocytes into five subpopulations.
    Type: Grant
    Filed: April 17, 2003
    Date of Patent: March 22, 2005
    Assignee: Clinical Diagnostics Solutions, Inc.
    Inventors: Harold Richardson Crews, Michael N. Elliott, James Harrison Carter, II
  • Patent number: 6858432
    Abstract: Automated staining equipment that can mix reagents is used to spray a Romanowsky stain onto slide mounted specimens which are then briefly centrifuged. The centrifugation step removes excess stain leaving only a thin film. Depending on the time of the centrifugation step, most of the organic solvent and part of the water in the stain are evaporated by airflow through the equipment. This greatly accelerates the staining reaction and preserves water soluble structures such as the granules in basophilic leukocytes. For optimal performance, this staining procedure requires a thiazin-eosin stain with about 90% to about 40% organic solvent, such as methanol, and only about 10% to about 60% water. This is a unique staining reagent in Romanowsky staining.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: February 22, 2005
    Assignee: Wescor, Inc.
    Inventors: Barry O. Stokes, Patti A. Nelson, Gary D. Bradshaw
  • Patent number: 6855552
    Abstract: The present invention provides reagents for use in an automated environment for cell conditioning of biological samples wherein the cells or tissues are predisposed for access by reagent molecules for histochemical and cytochemical staining procedures. The components of the reagents are optimized to facilitate molecular access to cells and cell constituents within the biological sample. The present invention also provides reagents for use in an automated environment for removing or etching embedding media by exposing a biological sample to be stained in histochemical or cytochemical procedures without the dependence on organic solvents. The components of the reagents are optimized to facilitate removal or etching of the embedding media from the biological sample.
    Type: Grant
    Filed: March 7, 2001
    Date of Patent: February 15, 2005
    Assignee: Ventana Medical Systems
    Inventors: Penny Towne, Joseph Utermohlen, Chad Wilkinson, Paula Rodgers, Kimberly Christensen, Ethel Macrea, Noemi Sebastiao
  • Patent number: 6846678
    Abstract: The present invention provides storage stable, aseptic buffer solutions suitable for gamma sterilization. The buffer solutions include benzethonium chloride as a biocide, and avoid the acidification effects and the formation of precipitates that can be caused by gamma sterilization.
    Type: Grant
    Filed: November 25, 2003
    Date of Patent: January 25, 2005
    Assignee: Terumo Cardiovascular Systems, Co.-Tustin
    Inventors: Matthew Romey, Mark Takagi
  • Publication number: 20040265170
    Abstract: The present invention provides a hydrogen peroxide indicator that includes a substrate on which is disposed an indicator composition that includes at least one of a select group of colorants. As a result of contact with hydrogen peroxide, the colorants change color, and even become colorless, thereby providing an indication of the presence of hydrogen peroxide.
    Type: Application
    Filed: July 14, 2004
    Publication date: December 30, 2004
    Applicant: 3M Innovative Properties Company
    Inventor: David M. Read
  • Patent number: 6830707
    Abstract: A temperature indicating material of the present invention includes at least an electron donating compound, an electron accepting compound, a reversible material causing reversible transformation between crystal and amorphous states, or reversible transformation between phase separation and non-phase-separation, with respect to a part or all of the composition system; and a temperature characteristic controller having a solid-state in room temperature and at least a part of the temperature characteristic controller dissolves in the electron accepting compound, the reversible material, or the electron accepting compound and the reversible material so as to change the speed of the reversible transformation between crystal and amorphous, or speed of the reversible transformation between phase separation and non-phase-separation, with respect to the composition system, by its reversible transformation between crystal and amorphous states, or the speed of the reversible transformation between phase separation and
    Type: Grant
    Filed: June 6, 2001
    Date of Patent: December 14, 2004
    Assignee: Toshiba Tec Kabushiki Kaisha
    Inventors: Toshiyuki Tamura, Takayuki Hiyoshi, Yuichiro Hatanaka
  • Patent number: 6821789
    Abstract: A collection container and method for collecting a predetermined volume of a biological sample, and particularly a whole blood sample, includes at least one gene induction blocking agent in an amount effective to stabilize and inhibit gene induction. The gene induction blocking agent is able to stabilize nucleic acids in the biological sample at the point of collection to block ex vivo gene induction in the sample when stored at room temperature. The stabilizing agents include cationic compounds, detergents, particularly cationic detergents, chaotropic salts, ribonuclease inhibitors, chelating agents, organic solvents, organic reducing reagents, and mixtures thereof. The biological sample is collected directly from the animal and immediately mixed with the gene induction blocking agent without any intermediate processing or handling.
    Type: Grant
    Filed: July 2, 2003
    Date of Patent: November 23, 2004
    Assignee: Becton, Dickinson and Company
    Inventors: Frank A. Augello, Lynne Rainen, Matthew Walenciak, Uwe Oelmüller, Ralf Wyrich, Helge Bastian
  • Patent number: 6811575
    Abstract: Method for invisibly marking a liquid petroleum hydrocarbon. The method comprises adding to the liquid petroleum hydrocarbon at least one dye selected from the group consisting of 1,4,5,8-tetrasubstituted anthraquinones and anthraquinone dimers. The absorption maximum of the dye(s) is in the range from 710 nm to 850 nm.
    Type: Grant
    Filed: December 3, 2002
    Date of Patent: November 2, 2004
    Assignee: Rohm and Haas Company
    Inventors: Kim Sang Ho, Yu-Min Chen
  • Publication number: 20040211940
    Abstract: The present invention provides a method for the measurement of the activity of a plasminogen activator, such as urokinase plasminogen activator (uPA) or tissue plasminogen activator (tPA) in a biological sample using an assay method characterized by the inclusion of an elastase inhibitor in the assay mixture. The invention also provides a diagnostic kit for the measurement of a plasminogen activator using said method and a method of determining the effective therapeutic dose of a plasminogen activator inhibitor using said method. Also provided is a method of preparing a pharmaceutical composition.
    Type: Application
    Filed: May 17, 2002
    Publication date: October 28, 2004
    Applicant: AstraZeneca AB
    Inventors: Paul Elvin, Philip Edwin Pinder
  • Publication number: 20040187564
    Abstract: Additives such as chemical elements, microstructures, time degradable molecules, micro oscillators (clocks) etc. are introduced into inks at production. The additives can be analyzed in samples thus giving source of and date of production. By varying additives over short time spans estimates of date of use may be obtained.
    Type: Application
    Filed: January 29, 2004
    Publication date: September 30, 2004
    Inventor: Jon C. Hagerty
  • Patent number: 6790411
    Abstract: The present invention provides a hydrogen peroxide indicator that includes a substrate on which is disposed an indicator composition that includes at least one of a select group of colorants. As a result of contact with hydrogen peroxide, the colorants change color, and even become colorless, thereby providing an indication of the presence of hydrogen peroxide.
    Type: Grant
    Filed: December 2, 1999
    Date of Patent: September 14, 2004
    Assignee: 3M Innovative Properties Company
    Inventor: David M. Read
  • Publication number: 20040162374
    Abstract: A marker paint comprises 42 wt % to 52 wt % pigment, 31 wt % to 37 wt % acrylic resin and 17 wt % to 21 wt % silicone resin excluding solvent. The pigment comprises cobalt titanium oxide, titanium nickel antimony oxide, cobalt aluminium oxide or cadmium sulphide selenium to give a green, yellow, blue or red colour respectively. The marker paint is used in conjunction with an irreversible temperature indicating paint to determine if there is any debris and/or dirt on the irreversible temperature indicating paint to affect the accuracy of the temperature measurement of the irreversible temperature indicating paint.
    Type: Application
    Filed: January 21, 2004
    Publication date: August 19, 2004
    Applicant: ROLLS-ROYCE PLC
    Inventors: Hugh M.L. Watson, Elaine C. Hodgkinson
  • Patent number: 6777240
    Abstract: The invention provides a class of samples that model the human body. This family of samples is based upon emulsions of oil in water with lecithin acting as the emulsifier. These solutions that have varying particle sizes may be spiked with basis set components (albumin, urea and glucose) to simulate skin tissues further. The family of samples is such that other organic compounds such as collagen, elastin, globulin and bilirubin may be added, as can salts such as Na+, K+and Cl−. Layers of varying thickness with known index of refraction and particle size distributions may be generated using simple crosslinking reagents, such as collagen (gelatin). The resulting samples are flexible in each analyte's concentration and match the skin layers of the body in terms of the samples reduced scattering and absorption coefficients, &mgr;'s and &mgr;a. This family of samples is provided for use in the medical field where lasers and spectroscopy based analyzers are used in treatment of the body.
    Type: Grant
    Filed: September 11, 2002
    Date of Patent: August 17, 2004
    Assignee: Sensys Medical, Inc.
    Inventors: Kevin H. Hazen, James Matthew Welch, Stephen F. Malin, Timothy L. Ruchti, Alexander D. Lorenz, Tamara L. Troy, Suresh Thennadil, Thomas B. Blank
  • Patent number: 6773637
    Abstract: The present invention is directed to a thermochromic temperature sensitive composition used to detect the prevailing temperature, and particularly, to detect when the temperature is within a particular range. When the temperature is within that range, the composition undergoes a color change that is visible to the observer.
    Type: Grant
    Filed: May 1, 2000
    Date of Patent: August 10, 2004
    Inventors: Gail D. DiSalvo, John Cusick
  • Patent number: 6773924
    Abstract: A method for separating and purifying the active hematinic species present in iron-saccharidic complexes including sodium ferric gluconate complex in sucrose, ferric hydroxide-sucrose complex and ferric saccharate complex and others of similar form and function, based on separation of the iron-saccharidic complex from one or more excipients and, preferably, lyophilization. Separation of the iron-saccharidic complex permits its analytical quantification; further concentration or purification as a new and useful product; preparation of redesigned formulations for new and useful pharmaceuticals; and/or lyophilization.
    Type: Grant
    Filed: February 21, 2003
    Date of Patent: August 10, 2004
    Assignee: Chromaceutical Advanced Technologies, Inc.
    Inventors: Robert A. Beck, Robert A. Mateer, Jr.
  • Patent number: 6770220
    Abstract: Luminescent microparticles and nanoparticles are provided for use either as internal standards for referencing fluorescent signals, or as markers for detecting biomolecules. Luminescence dyes are incorporated in inert form into solid materials such that they are protected from the influence of chemical and biological compounds in aqueous sample constituents. The photophysical characteristics of the dyes (spectral characteristics, luminescence quantum efficiency, luminescence fading time and polarization) remain unaffected. The surface of the nanoparticles and microparticles can be provided with reactive surfaces in order to enable covalent coupling of biochemicals or to eliminate aggregation.
    Type: Grant
    Filed: January 15, 2002
    Date of Patent: August 3, 2004
    Assignee: Presens Precision Sensing GmbH
    Inventor: Ingo Klimant
  • Publication number: 20040135125
    Abstract: Fluorescent monomers are described and claimed which are synthesized by reacting a substituted or non-substituted naphthalic anhydride with an amine and with a moiety containing a polymerizable group. Such monomers are useful for the preparation of tagged treatment polymers. Such tagged treatment polymers are useful as scale inhibitors in industrial water systems.
    Type: Application
    Filed: September 9, 2003
    Publication date: July 15, 2004
    Inventors: John D. Morris, Barbara E. Moriarty, Mingli Wei, Patrick G. Murray, Jerry L. Reddinger
  • Publication number: 20040135124
    Abstract: Fluorescent monomers are described and claimed which are synthesized by reacting a substituted or non-substituted naphthalic anhydride with an amine and with a moiety containing a polymerizable group. Such monomers are useful for the preparation of tagged treatment polymers. Such tagged treatment polymers are useful as scale inhibitors in industrial water systems.
    Type: Application
    Filed: September 9, 2003
    Publication date: July 15, 2004
    Inventors: John D. Morris, Barbara E. Moriarty, Mingli Wei, Patrick G. Murray, Jerry L. Reddinger
  • Patent number: 6759246
    Abstract: A control composition, and method of preparing a control composition, that includes stabilized, mammalian granulocytes having altered physical properties so that the granulocytes function as a human lymphocyte analogs when used on an automated blood cell analyzer.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: July 6, 2004
    Assignee: Research & Diagnostic Systems, Inc.
    Inventor: Mark Collins
  • Patent number: 6750756
    Abstract: A method for associating information with an article, an isotopic labeling composition to label an article with information using at least two different isotopes of an element, and an article labeled with the labeling composition. In the labeling composition, the isotopes of the labeling composition have an abundance ratio that is detectably different from the natural abundance ratio thereof. By detecting the abundance ratio(s) of the isotopes in the labeling composition, via laser ablation/magnetic spectroscopy, an NQR spectrometer, an NMR spectrometer, an IR spectrometer, or a microwave spectrometer, information about the article can be determined. The method and labeling composition may be used to identify, authenticate or determine the source or origin of an article or to provide detailed information about an article.
    Type: Grant
    Filed: August 7, 2002
    Date of Patent: June 15, 2004
    Assignee: Theragenics Corporation
    Inventors: Nigel R. Stevenson, John M. Dawson, Lee Heflinger
  • Publication number: 20040107765
    Abstract: A surface acoustic wave gas sensor for detecting predetermined substances includes a piezoelectric substrate, an input transducer and an output transducer which is formed on the piezoelectric substrate, and a sensitive film which is formed between the input transducer and the output transducer and detects at least one of acetone, benzene, dichloroethane, ethanol, and toluene. The sensitive film includes mercaptoundecanoic acid and CMP composed of cellulose nitrate, dibutyl phthalate, compound of benzene and ethanol, ethyl acetate. The surface acoustic wave gas sensor can quickly detect even small amounts of these substances.
    Type: Application
    Filed: December 3, 2003
    Publication date: June 10, 2004
    Inventors: Kun-Hyung Lee, Jung-Sung Hwang, Seung-Yeon Cho
  • Patent number: 6746630
    Abstract: The claims are drawn to a method of detecting seal breakage or incomplete seal formation in a package, said method comprising the steps of: (i) providing said package, prior to sealing, with a strip or ring of an indicator comprising an oxygen scavenging composition which includes a source of labile hydrogen or electrons and at least one reducible organic compound, wherein said strip or ring is located on an internal surface adjacent to where a seal is to be formed, (ii) treating the strip or ring with electromagnetic energy so as to reduce the reducible organic compound to a reduced form which is oxidizable by ground state molecular oxygen regardless of the presence of a transition metal catalyst and such that, when oxidized, there is a detectable change in a characteristic of said composition selected from the group consisting of: colour, fluorescence emission and UV-visible, infrared or near-infrared absorption, (iii) subjecting said package to a sealing process intended to seal the package, and (iv) detec
    Type: Grant
    Filed: January 17, 2003
    Date of Patent: June 8, 2004
    Assignee: Commonwealth Scientific and Industrial Research Organisation
    Inventor: Michael Laurence Rooney
  • Publication number: 20040089847
    Abstract: The invention relates to a stain solution, which is devoid of phenol, for staining bacteria. Said solution contains at least one dye, one solvent and one of the following substances, or mixtures thereof, as a phenol substitute: 2-butoxy thylacetate, 2-phenylethanol, benzyl alcohol, 4-methoxyphenol or cyclohexanol.
    Type: Application
    Filed: November 14, 2002
    Publication date: May 13, 2004
    Inventors: Andreas Rauh, Daniela Grabis, Evangelos Thomas, Dorothee Meier
  • Publication number: 20040082070
    Abstract: Systems and methods for establishing and/or maintaining the accuracy of a multivariate calibration model designed for quantitative optical spectroscopic measurement of attributes or analytes in bodily tissues, bodily fluids or other biological samples, which are particularly useful when the spectral absorbance of the attribute or analyte is small relative to the background. The present invention provides an optically similar reference sample to reduce the effect of instrument or environment variation on the measurement capability of the model. The optically similar reference can be a gel composition having scattering particles suspended therein. The reference gel can be directly applied to a spectroscopic instrument sampler, or can be in a container specifically designed for optimal coupling to a spectroscopic instrument.
    Type: Application
    Filed: October 28, 2002
    Publication date: April 29, 2004
    Inventors: Howland D. T. Jones, David J. Nunez, Stephen J. Vanslyke, Robert D. Johnson, Edward L. Hull
  • Publication number: 20040067591
    Abstract: Tissue mimicking materials for elastography phantoms have elastic, ultrasound, and magnetic resonance characteristics that are characteristic of human soft tissues and well suited for the calibration and performance assessment of elastography imaging systems. In one embodiment, the material is formed from a base material containing an oil dispersed within a gel matrix and at least one inclusion formed from a gel. In another embodiment, the material is formed from a gel-forming material suffused throughout an open-cell reticulated mesh matrix.
    Type: Application
    Filed: October 4, 2002
    Publication date: April 8, 2004
    Applicant: Wisconsin Alumni Research Foundation
    Inventors: Ernest L. Madsen, Gary R. Frank
  • Patent number: 6712996
    Abstract: The invention relates to temperature indicating compositions which display temperature dependent color changes. The invention encompasses temperature indicating compositions, materials, devices and methods of their use. The temperature indicating compositions of the invention are clays that can be used to detect temperature and temperature changes at sub-ambient and particularly sub-zero ° C. temperatures. Temperature of a selected environment can be monitored by placing a temperature-sensitive composition comprising the clay material of this invention in contact with that environment and monitoring the color of the composition.
    Type: Grant
    Filed: June 19, 2001
    Date of Patent: March 30, 2004
    Inventors: Jun Wu, Yaomin Xia, Joseph W. Stucki
  • Publication number: 20040051081
    Abstract: An indicating desiccant comprises a silica-based material having impregnated thereon a source of copper and a source of bromide, the source of copper being present in an amount up to 0.5 per cent by weight, calculated as Cu with respect to weight of the silica-based material, and the source of bromide being present in an amount such that the weight ration of Br to Cu is at least 5:1. Optionally, the indicating desiccant also comprises a dye or other coloured material.
    Type: Application
    Filed: July 17, 2003
    Publication date: March 18, 2004
    Inventor: Stephen Moreton
  • Patent number: 6706526
    Abstract: A low formaldehyde containing aqueous blood diluent contains an effective amount of ethylenediamine tetraacetic acid, ethylenediamine tetraacetic acid derivative, or combinations thereof; an effective amount of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one; and an effective amount of 5-bromo-5-nitro-1,3-dioxane. Advantageously, less than about 1 parts per million of formaldehyde is produced in this multipurpose diluent. A method of analyzing a blood sample containing blood cells is conducted by forming a diluted blood sample by mixing a blood sample containing blood cells with this diluent and analyzing the diluted blood sample to determine a physical parameter of the blood cells.
    Type: Grant
    Filed: January 24, 2002
    Date of Patent: March 16, 2004
    Assignee: Coulter International Corp.
    Inventors: Russell F. Lang, Iris L. Payan, Barbara G. Murza, Luisa C. Oramas